Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: A meta-analysis

Coronary Artery Disease

Volumn 13, Issue 8, 2002, Pages 427-436

  Klein, Werner W ^a,d   Jackson, Graham ^b   Tavazzi, Luigi ^c  

^a UNIVERSITY OF GRAZ   (Austria)

^b LONDON BRIDGE HOSPITAL   (United Kingdom)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

blocker; Calcium antagonist; Chronic stable angina; Combined antianginal drugs; Meta analysis; Monotherapy

Indexed keywords

AMLODIPINE; ATENOLOL; BEPRIDIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DILTIAZEM; FELODIPINE; LIDOFLAZINE; METOPROLOL; NICARDIPINE; NIFEDIPINE; NISOLDIPINE; NITRATE; OXPRENOLOL; PROPRANOLOL;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EXERCISE TEST; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; STABLE ANGINA PECTORIS; TREADMILL;

ADRENERGIC BETA-ANTAGONISTS; ANGINA PECTORIS; CALCIUM CHANNEL BLOCKERS; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CROSS-OVER STUDIES; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; EXERCISE TEST; HUMANS; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036968481     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200212000-00008     Document Type: Article

References (46)

1. Management of stable angina pectoris: recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 1997; 18:394-413.
2. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 1999; 33:2092-2197.
3. Pepine CJ, Abrams J, Marks RG, Morris JJ, Scheidt SS, Handberg E, for the TIDES investigators. Characteristics of a contemporary population with angina pectoris. Am J Cardiol 1994; 74:226-231.
4. Cohn PF. Pharmacological treatment of ischaemic heart disease. Monotherapy vs combination therapy. Eur Heart J 1997; 18(suppl B):B27-B34.
5. Heidenreich PA, McDonald KM, Hastie T, Fadel B, Hagan V, Lee BK, et al. Meta-analysis of trials comparing β-blockers, calcium antagonists, and nitrates for stable angina. JAMA 1999; 281:1927-1936.
6. Dargie HJ, Ford I, Fox KM, on behalf of the Total Ischaemic Burden European Trial (TIBET) study group. Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. Eur Heart J 1996; 17:104-112.
7. Friedensohn A, Meshulam R, Schlesinger Z. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes. Cardiology 1991; 79(suppl 2):31-40.
8. Hedges LV. Estimation of effect size from a series of independent experiments. Psychol Bull 1982; 92:490-499.
9. Wang MC, Bushman BJ. Integrating Results through Meta-analytic Review using SAS software. Cary, North Carolina: SAS Institute; 1999.
10. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF, for the QUOROM Group. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999; 354:1896-1900.
11. Tweddel AC, Beattie JM, Murray RG, Hutton I. The combination of nifedipine and propanolol in the management of patients with angina pectoris. Br J Clin Pharmacol 1981; 12:229-233.
12. Jenkins RM, Nagle RE. The symptomatic and objective effects of nifedipine in combination with beta-blocker therapy in severe angina pectoris. Postgrad Med J 1982; 58:697-700.
13. Strauss WE, Parisi AF. Randomized, placebo-controlled evaluation of lidoflazine in patients receiving beta-blocker therapy with propanolol: improvement in anginal symptoms and exercise tolerance with combined drug therapy. Am J Cardiol 1984; 53:1003-1007.
14. Frishman WH, Charlap S, Farnham DJ, Sawin HS, Michelson EL, Crawford MH, et al. Combination propanolol and bepridil therapy in stable angina pectoris. Am J Cardiol 1985; 55:43C-49C.
15. Strauss WE, Parisi AF. Superiority of combined diltiazem and propanolol therapy for angina pectoris. Circulation 1985; 71:951-957.
16. O'Keefe JC, Creamer JE, Banim SO. Efficacy of nisoldipine combined with beta-adrenergic-blocking drugs in the treatment of chronic stable angina. Clin Cardiol 1987; 10:345-350.
17. Akhras F, Jackson G. Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina. Lancet 1991; 338:1036-1039.
18. Foale RA. Atenolol versus the fixed combination of atenolol and nifedipine in stable angina pectoris. Eur Heart J 1993; 14:1369-1374.
19. Meyer TE, Adnams C, Commerford P. Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina. Cardiovasc Drugs Ther 1993; 7:909-913.
20. Madjlessi-Simon T, Fillette F, Mary-Krause M, Lechat P, Jaillon P, on behalf of the amlor-Holter study investigators. Eur Heart J 1995; 16:1780-1788.
21. Dunselman PHJM, van Kempen LHJ, Beuwens LHM, Holwerda KJ, Herweijer AH, Bernink PJLM. Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade. Am J Cardiol 1998; 81:128-132.
22. Donaldson KM, Dawkins KD, Waller DG. A comparison of nisoldipine and nifedipine, in combination with atenolol, in the management of myocardial ischaemia. Eur Heart J 1993; 14:534-539.
23. Savonitto S, Ardissino D, Egstrup K, Rasmussen K, Bae EA, Omland T, et al. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. J Am Coll Cardiol 1996; 27:311-316.
24. Hung J, Lamb IH, Connolly SJ, Jutzy KR, Goris ML, Schroeder JS. The effect of diltiazem and propanolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study. Circulation 1983; 68:560-567.
25. Kenny J, Kiff P, Holmes J, Jewitt DE. Beneficial effects of diltiazem and propanolol, alone and in combination, in patients with stable angina pectoris. Br Heart J 1985; 53:43-46.
26. Humen DP, O'Brien P, Purves P, Johnson D, Kostuk WJ. Effort angina with adequate beta-receptor blockade: comparison with diltiazem alone and in combination. J Am Coll Cardiol 1986; 7:329-335.
27. Uusitalo A, Arstila M, Bae EA, Härkönen R, Keyrilâinen O, Rytkönen U, et al. Metoprolol, nifedipine, and the combination in stable effort angina pectoris. Am J Cardiol 1986; 57:733-737.
28. El-Tamimi H, Davies GJ. Optimal control of myocardial ischaemia: the benefit of a fixed combination of atenolol and nifedipine in patients with chronic stable angina. Br Heart J 1992; 68:291-295.
29. Parameshwar J, Keegan J, Mulcahy D, Phadke K, Sparrow J, Sutton GC, et al. Atenolol or nicardipine alone is as efficacious in stable angina as their combination: a double-blind randomised trial. Int J Cardiol 1993; 40:135-141.
30. Fox KM, Mulcahy D, Findlay I, Ford I, Dargie H, on behalf of the Total Ischaemic Burden European Trial (TIBET) Study Group. Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. Eur Heart J 1996; 17:96-103.
31. Dunselman P, Liem AH, Verdel G, Kragten H, Bosmal A, Bernink P, on behalf of the FEMINA Study Group of the Working Group on Cardiovascular Research, the Netherlands (WCN). Addition of felodipine to metoprolol vs replacement of metoprolol by felodipine in patients with angina pectoris despite adequate beta-blockade. Eur Heart J 1997; 18:1755-1764.
32. Emanuelsson H, Egstrup K, Nikus K, Ellström J, Glud T, Pater C, et al. Antianginal efficacy of the combination of felodipine-metoprolol 10/mg compared with each drug alone in patients with stable angina pectoris: a multicenter parallel group study. Am Heart J 1999; 137:854-862.
33. Dargie HJ, Grant S, McLenachan J. Angina, ischemia, and effort tolerance with betablockers. Am Heart J 1991; 121:1017-1020.
34. Ardissino D, Savonitto S, Egstrup K, Rasmussen K, Bae EA, Omland T, et al. Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) study. J Am Coll Cardiol 1995; 25:1516-1521.
35. Areskog NH. Effects and adverse effects of autonomic blockade in physical exercise. Am J Cardiol 1985; 55:132D-134D.
36. Ferguson JD, Ormerod O, Lenox-Smith AJ. Bisoprolol alone and in combination with amlodipine or nifedipine in the treatment of chronic stable angina. Int J Clin Pract 2000; 54:360-363.
37. Pehrsson SK, Ringqvist I, Ekdahl S, Karlson BW, Ulvenstam G, Persson S. Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris. Clin Cardiol 2000; 23:763-770.
38. Begg CB, Berlin JA. Publication bias: a problem in interpreting medical data. J R Statist Soc 1988; 151:419-463.
39. Pogue J, Yusuf S. Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 1998; 351:47-52.
40. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomised controlled trials published in English and German. Lancet 1997; 350:326-329.
41. Packer M. Combined beta-adrenergic and calcium-entry blockade in angina pectoris. N Engl J Med 1989; 320:709-718.
42. Rossinen J, Partanen J, Nieminen MS. Amlodipine in patients with stable angina pectoris treated with beta-blockers. Scand Cardiovasc J 1998; 32:41-48.
43. Owens P, O'Brien E. Hypotension with coronary disease: can profound hypotensive events cause myocardial ischaemic events?. Heart 1999; 82:477-481.
44. Edoute Y, Nagachandran P, Svirski B, Ben-Ami H. Cardiovascular adverse drug reaction associated with combined β-adrenergic and calcium entry-blocking agents. J Cardiovasc Pharmacol 2000; 35:556-559.
45. Thadani U. Treatment of stable angina. Curr Opin Cardiol 1999; 14:349-358.
46. Davies RF, Habibi H, Klinke WP, Dessain P, Nadeau C, Phaneuf DC, et al., for the Canadian amlodipine/atenolol in silent ischemia study (CASIS) investigators. J Am Coll Cardiol 1995; 25:619-625.